📰 Pharma Co News
Page 2 - Pharma Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Co. Real-time updates on events, politics, business and more.
October 11, 2022
Love Pharma adding to its addiction treatment portfolio with transdermal IP acquisition for opioid antagonist drug NaltrexoneNaltrexone primarily used to treat alcohol and or opioid use disorder and is
September 7, 2022
Starton Therapeutics is a leading clinical stage Biotechnology Company based in New Jersey led by CEO and Chairman, Mr. Pedro Lichtinger, Former President of Global Primary Care & President of Europe at
August 25, 2022
Love Pharma President, Mr. Zach Stadnyk, delivers comprehensive report on the Company's holdings and growth strategyBuilding upon the Company's major research initiative, led by an addiction research leader
May 14, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
March 7, 2022
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received fu...
March 3, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
March 3, 2022
VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company is pleased to announce updated details on the proposed Microdoz Therapy acquisition
March 3, 2022
Love Pharma Updates Microdoz Proposed Acquisition with Global Leader in Psychedelic Research - read this article along with other careers information, tips and advice on BioSpace
October 20, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation.
October 6, 2021
Longtime Marketing, Development, and Sales Executive to Head Day-to-Day Operations for Emerging Sexual Health, Wellness, and Psychedelics BrandVANCOUVER, BC / ACCESSWIRE / October 6, 2021 / LOVE Pharma